Contact lenses for antifungal ocular drug delivery: A review

Expert Opinion on Drug Delivery

Volumn 11, Issue 4, 2014, Pages 537-546

  Phan, Chau Minh ^a   Subbaraman, Lakshman ^a   Jones, Lyndon ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Antifungal; Contact lens; Cornea; Hydrogel; Ocular drug delivery

Indexed keywords

ALLYLAMINE; ALPHA TOCOPHEROL; ANTIFUNGAL AGENT; CYCLODEXTRIN; ECONAZOLE; FLUCONAZOLE; MICONAZOLE; NAFTIFINE; NATAMYCIN; POLYELECTROLYTE; POLYENE; TERBINAFINE;

COMMERCIAL PHENOMENA; CONTACT LENS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; EMBEDDING; HUMAN; HYDROGEL; MOLECULAR IMPRINTING; NONHUMAN; PATENT; REVIEW;

ANIMALS; ANTIFUNGAL AGENTS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CONTACT LENSES; CORNEAL ULCER; DRUG DELIVERY SYSTEMS; EYE INFECTIONS, FUNGAL; HUMANS;

EID: 84897880819     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2014.882315     Document Type: Review

References (98)

1. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bulettin World Health Organ 2001;79:214-21
2. Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 2003;16:730-97
3. Bharathi MJ, Ramakrishnan R, Vasu S, et al. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Ind J Ophthalmol 2003;51:315-21
4. O'Day DM. Selection of appropriate antifungal therapy. Cornea 1987;6:238-45
5. Loh AR, Hong K, Lee S, et al. Practice patterns in the management of fungal corneal ulcers. Cornea 2009;28:856-9
6. Kaur IP, Rana C, Singh H. Development of effective ocular preparations of antifungal agents. J Ocul Pharmacol 2008;24:481-94
7. Li Y, Sun SJ, Guo QJ, et al. In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves. J Antimicrob Chemother 2008;61:577-85
8. Saettone MF. Progress and problems in ophthalmic drug delivery. Pharmatech 20021-6
9. Kumar A, Malviya R, Sharma PK. Recent trends in ocular drug delivery: a short review. Eur J Appl Sci 2011;3:86-92
10. Shell JW. Pharmacokinetics of topically applied ophthalmic drugs. Surv Ophthalmol 1982;26:207-18
11. Ghate D, Edelhauser HF. Barriers to glaucoma drug delivery. J Glaucoma 2008;17:147-56
12. Patton TF, Francoeur M. Ocular bioavailability and systemic loss of topically applied ophthalmic drugs. Am J Ophthalmol 1978;85:225-9
13. Yolton DP. Antiinfective drugs. In: Bartlett JD, Jaanus SD, editors. Clin ocular pharmacology. 4th edition. Butterworth-Heineman; Woburn, MA: 2001. p. 219-64
14. Gurwitz JH, Glynn RJ, Monane M, et al. Treatment for glaucoma: adherence by the elderly. Am J Public Health 1993;83:711-16
15. Rotchford AP, Murphy KM. Compliance with timolol treatment in glaucoma. Eye (Lond) 1998;12(Pt 2):234-6
16. Trawick AB. Potential systemic and ocular side effects associated with topical administration of timolol maleate. J Am Optom Assoc 1985;56:108-12
17. Paugh JR, Stapleton F, Keay L, et al. Tear exchange under hydrogel contact lenses: methodological considerations. Invest Ophthalmol Vis Sci 2001;42:2813-20
18. Lin MC, Soliman GN, Lim VA, et al. Scalloped channels enhance tear mixing under hydrogel contact lenses. Optom Vis Sci 2006;83:874-8
19. Hehl EM, Beck R, Luthard K, et al. Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of Acuvue contact lenses. Eur J Clin Pharmacol 1999;55:317-23
20. Li CC, Chauhan A. Modeling ophthalmic drug delivery by soaked contact lenses. Ind Eng Chem Res 2006;45:3718-34
21. Wichterle O, Lm D. Hydrophilic gels for biological use. Nature 1960;185:117-18
22. Sedlacek J. Possibilities of application of eye drugs with the aid of gel-contact lenses. Cesk Slov Ophthalmol 1965;21:509-12
23. Peng CC, Kim J, Chauhan A. Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers. Biomaterials 2010;31:4032-47
24. Fonn D, Bruce AS. A review of the Holden-Mertz criteria for critical oxygen transmission. Eye Contact Lens 2005;31:247-51
25. Holden BA, Sankaridurg PR, Sweeney DF, et al. Microbial keratitis in prospective studies of extended wear with disposable hydrogel contact lenses. Cornea 2005;24:156-61
26. Stapleton F, Stretton S, Papas E, et al. Silicone hydrogel contact lenses and the ocular surface. Ocul Surf 2006;4:24-43
27. Brennan NA, Coles M, Comstock TL, et al. A 1-year prospective clinical trial of balafilcon A (PureVision) siliconehydrogel contact lenses used on a 30-day continuous wear schedule. Ophthalmology 2002;109:1172-7
28. Kaur IP, Kakkar S. Topical delivery of antifungal agents. Expert Opin Drug Deliv 2010;7:1303-27
29. Mathews MS, Kuriakose T. Keratitis due to Cephaliophora-Irregularis Thaxter. J Med Vet Mycol 1995;33:359-60
30. Ritterband DC, Seedor JA, Shah MK, et al. A unique case of Cryptococcus laurentii keratitis spread by a rigid gas permeable contact lens in a patient with onychomycosis. Cornea 1998;17:115-18
31. Rosa RHJr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology 1994;101:1005-13
32. O'Brien TP. Therapy of ocular fungal infections. Ophthalmol Clin North Am 1999;12:33-50
33. teWelscher YM, Hendrik H, Balague MM, et al Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane. J Biol Chem 2008 283 6393-401
34. Stark J, Rijn VFTJ, Krieken VDWM, et al. A new antifungal composition. EP2053921; 2009
35. Thomas A. Analysis and assay of polyene antifungal antibiotics. A review. Analyst 1976;101:321-40
36. Dekker J, Ark P. Protection of antibiotic pimaricin from oxidation and ultraviolet light by chlorophyllin and other compounds. Antibiot Chemother 1959;9:327-32
37. Phan CM, Subbaraman LN, Jones L. In vitro uptake and release of natamycin from conventional and silicone hydrogel contact lens materials. Eye Contact Lens 2013;39:162-8
38. Ernest JM. Topical antifungal agents. Obstet Gynecol Clin North Am 1992;19:587-607
39. Byrne M, Collins A, Vaughan A, et al. Therapeutic contact lenses with antifungal delivery. WO2008060574; 2008
40. dos Santos JF, Torres-Labandeira JJ, Matthijs N, et al. Functionalization of acrylic hydrogels with alpha-, beta- or gamma-cyclodextrin modulates protein adsorption and antifungal delivery. Acta Biomater 2010 6 3919-26
41. Galarreta DJ, Tuft SJ, Ramsay A, et al. Fungal keratitis in London: microbiological and clinical evaluation. Cornea 2007;26:1082-6
42. Foster CS. Miconazole therapy for keratomycosis. Am J Ophthalmol 1981;91:622-9
43. Fitzsimons R, Peters AL. Miconazole and ketoconazole as a satisfactory 1st-line treatment for keratomycosis. Am J Ophthalmol 1986;101:605-8
44. Balfour JA, Faulds D. Terbinafine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992;43:259-84
45. Sen M, Yakar A. Controlled release of antifungal drug terbinafine hydrochloride from poly(N-vinyl 2-pyrrolidone/itaconic acid) hydrogels. Int J Pharm 2001;228:33-41
46. Machin R, Isasi JR, Velaz I. beta-cyclodextrin hydrogels as potential drug delivery systems. Carbohydr Polym 2012;87:2024-30
47. O'Neil MJ. editor. The Merck index: an encyclopedia of chemical, drugs, and biologicals. Merck; New Jersey, USA: 2006
48. Karlgard C, Wong N, Jones L, et al. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int J Pharm 2003;257:141-51
49. Brazel CS, Peppas NA. Modeling of drug release from swellable polymers. Eur J Pharm Biopharm 2000;49:47-58
50. Arun A, Reddy BSR. In vitro drug release studies from the polymeric hydrogels based on HEA and HPMA using 4-{(E)-[(3Z)-3- (4-(acryloyloxy) benzylidene)-2- hexylidene]methyl}lphenyl acrylate as a crosslinker. Biomaterials 2005;26:1185-93
51. Coughlan DC, Quilty FP, Corrigan OI. Effect of drug physicochemical properties on swelling/deswelling kinetics and pulsatile drug release from thermoresponsive poly (N-isopropylacrylamide) hydrogels. J Control Release 2004;98:97-114
52. Varshosaz J, Koopaie N. Cross-linked poly (vinyl alcohol) hydrogel: study of swelling and drug release behaviour. Iran Polym J 2002;11:123-31
53. Kim SW, Bae YH, Okano T. Hydrogels: swelling, drug loading, and release. Pharm Res 1992;9:283-90
54. Hui A, Boone A, Jones L. Uptake and release of ciprofloxacin-HCl from conventional and silicone hydrogel contact lens materials. Eye Contact Lens 2008;34:266-71
55. Hiratani H, Alvarez-Lorenzo C. Timolol uptake and release by imprinted soft contact lenses made of N,Ndiethylacrylamide and methacrylic acid. J Control Release 2002;83:223-30
56. Ciolino JB, Hoare TR, Iwata NG, et al. A drug-eluting contact lens. Invest Ophthalmol Vis Sci 2009;50:3346-52
57. Ali M, Horikawa S, Venkatesh S, et al. Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow. J Control Release 2007;124:154-62
58. Brohede U, Frenning G, Stromme M. Characterization of the drug release process by investigation of its temperature dependence. J Pharm Sci 2004;93:1796-803
59. Pitt WG, Jack DR, Zhao Y, et al. Loading and release of a phospholipid from contact lenses. Optom Vis Sci 2011;88:502-6
60. Karlgard CC, Jones LW, Moresoli C. Survey of bandage lens use in North America, October-December 2002. Eye Contact Lens 2004;30:25-30
61. Lim L, Tan D, Chan WK. Therapeutic use of Bausch & Lomb PureVision contact lenses. Contact Lens Assoc Ophthalmol J 2001;27:179-85
62. Arora R, Jain S, Monga S, et al. Efficacy of continuous wear PureVision contact lenses for therapeutic use. Contact Lens Ant Eye 2004;27:39-43
63. Foulks G, Harvey T, Raj C. Therapeutic contact lenses: the role of high-Dk lenses. Ophthalmol Clin North Am 2003;16:455
64. Engle AT, Laurent JM, Schallhorn SC, et al. Masked comparison of silicone hydrogel lotrafilcon A and etafilcon A extended-wear bandage contact lenses after photorefractive keratectomy. J Cataract Refract Surg 2005;31:681-6
65. Brilakis HS, Deutsch TA. Topical tetracaine with bandage soft contact lens pain control after photorefractive keratectomy. J Refract Surg 2000;16:444-7
66. Karlgard C, Jones L, Moresoli C. Ciprofloxacin interaction with siliconbased and conventional hydrogel contact lenses. Eye Contact Lens 2003;29:83-9
67. Silbert JA. A review of therapeutic agents and contact lens wear. J Am Optom Assoc 1996;67:165-72
68. Boone A, Hui A, Jones L. Uptake and release of dexamethasone phosphate from silicone hydrogel and group I, II, and IV hydrogel contact lenses. Eye Contact Lens 2009;35:260-7
69. Gulsen D, Chauhan A. Ophthalmic drug delivery through contact lenses. Invest Ophthalmol Vis Sci 2004;45:2342-7
70. Alvarez-Lorenzo C, Concheiro-Nine A. Drug-loaded soft contact lenses. Arch Soc Esp Ophthalmol 2008;83:73-4
71. Ciolino JB, Hudson SP, Mobbs AN, et al. A prototype antifungal contact lens. Invest Ophthalmol Vis Sci 2011;52:6286-91
72. Ende MTA, Peppas NA. Transport of ionizable drugs and proteins in crosslinked poly(acrylic acid) and poly (acrylic acid-co-2-hydroxyethyl methacrylate) hydrogels. 2. Diffusion and release studies. J Control Release 1997;48:47-56
73. Alvarez-Lorenzo C, Hiratani H, Gomez-Amoza JL, et al. Soft contact lenses capable of sustained delivery of timolol. J Pharm Sci 2002;91:2182-92
74. Alvarez-Lorenzo C, Concheiro A. Molecularly imprinted polymers for drug delivery. J Chromatogr B Analyt Technol Biomed Life Sci 2004;804:231-45
75. Rasheed A, Kumar A, Sravanthi V. Cyclodextrins as drug carrier molecule: a review. Sci Pharm 2008;76:567-98
76. Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications. Int J Pharm 2007;329:1-11
77. Koontz JL, Marcy JE. Formation of natamycin:cyclodextrin inclusion complexes and their characterization. J Agric Food Chem 2003;51:7106-10
78. Yang W, Chow KT, Lang B, et al. In vitro characterization and pharmacokinetics in mice following pulmonary delivery of itraconazole as cyclodextrin solubilized solution. Eur J Pharm Sci 2010;39:336-47
79. Upadhyay SK, Kumar G. NMR and molecular modelling studies on the interaction of fluconazole with beta-cyclodextrin. Chem Cent J 2009;3:9
80. Rajagopalan N, Chen SC, Chow WS. A study of the inclusion complex of amphotericin-B with gamma-cyclodextrin. Int J Pharm 1986;29:161-8
81. Hostetler JS, Hanson LH, Stevens DA. Effect of cyclodextrin on the pharmacology of antifungal oral azoles. J Antimicrob Chemother 1992;36:477-80
82. Liu YY, Fan XD, Hu H, et al. Release of chlorambucil from poly (N-isopropylacrylamide) hydrogels with beta-cyclodextrin moieties. Macromol Biosci 2004;4:729-36
83. Liu YY, Fan XD, Kang T, et al. A cyclodextrin microgel for controlled release driven by inclusion effects. Macromol Rapid Commun 2004;25:1912-16
84. Kanjickal D, Lopina S, Evancho-Chapman MM, et al. Improving delivery of hydrophobic drugs from hydrogels through cyclodextrins. J Biomed Mater Res A 2005;74A:454-60
85. Siemoneit U, Schmitt C, Alvarez-Lorenzo C, et al. Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capability. Int J Pharm 2006;312:66-74
86. Thatiparti TR, von Recum HA. Cyclodextrin complexation for affinitybased antibiotic delivery. Macromol Biosci 2010;10:82-90
87. Xu J, Li X, Sun F, et al. PVA hydrogels containing beta-cyclodextrin for enhanced loading and sustained release of ocular therapeutics. J Biomater Sci Polym Ed 2010;21:1023-38
88. Subbaraman LN, Jones L. Kinetics of lysozyme activity recovered from conventional and silicone hydrogel contact lens materials. J Biomater Sci Polym Ed 2010;21:343-58
89. Mosbach K, Ramstrom O. The emerging technique of molecular imprinting and its future impact on biotechnology. Bio Technol 1996;14:163-70
90. Hui A, Sheardown H, Jones L. Acetic and acrylic acid molecular imprinted model silicone hydrogel materials for ciprofloxacin-HCl delivery. Materials 2012;5:85-107
91. Phan CM, Subbaraman L, Liu S, et al. In vitro uptake and release of natamycin Dex-b-PLA nanoparticles from model contact lens materials. J Biomater Sci Polym Ed 2013
92. Barbosa TM, Levy SB. The impact of antibiotic use on resistance development and persistence. Drug Res Updates 2000;3:303-11
93. Saigal N, Baboota S, Ahuja A, et al. Multiple-pulse drug delivery systems: setting a new paradigm for infectious disease therapy. Expert Opin Drug Deliv 2009;6:441-52
94. Wang J, Fonn D, Simpson TL, et al. Precorneal and pre- and postlens tear film thickness measured indirectly with optical coherence tomography. Invest Ophthalmol Vis Sci 2003;44:2524-8
95. Peng CC, Ben-Shlomo A, Mackay EO, et al. Drug delivery by contact lens in spontaneously glaucomatous dogs. Curr Eye Res 2012;37:204-11
96. Tieppo A, White CJ, Paine AC, et al. Sustained in vivo release from imprinted therapeutic contact lenses. J Control Release 2012;157:391-7
97. Lee PI, Kim CJ. Probing the mechanisms of drug release from hydrogels. J Control Release 1991;16:229-36
98. Kim CJ, Lee PI. Effect of loading on swelling-controlled drug release from hydrophobic polyelectrolyte gel beads. Pharm Res 1992;9:1268-74